Andrew X. Zhu

Kinetic Textural Biomarker for Predicting Survival of Patients with Advanced Hepatocellular Carcinoma After Antiangiogenic Therapy by Use of Baseline First-Pass Perfusion CT

Hiroyuki Yoshida, Sang Ho Lee, Dushyant V. Sahani, 2014, ABDI@MICCAI.

Parameter Comparison Between Fast-Water-Exchange-Limit-Constrained Standard and Water-Exchange-Modified Dual-Input Tracer Kinetic Models for DCE-MRI in Advanced Hepatocellular Carcinoma

Hiroyuki Yoshida, Sang Ho Lee, Dushyant V. Sahani, 2014, ABDI@MICCAI.

Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles

Chris Sander, Peter W. Laird, Chandra Sekhar Pedamallu, 2017, Cell reports.

Fractal Analysis of Contrast-Enhanced CT Images to Predict Survival of Patients with Hepatocellular Carcinoma Treated with Sunitinib

Hiroyuki Yoshida, Dushyant V. Sahani, Koichi Hayano, 2014, Digestive Diseases and Sciences.

Radiation therapy for liver tumors: ready for inclusion in guidelines?

Andrew X. Zhu, Laura A. Dawson, L. Dawson, 2014, The oncologist.

Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise

Andrew X. Zhu, Gabriel A. Brooks, Charles S. Fuchs, 2016, The oncologist.

Biomarkers of response and resistance to antiangiogenic therapy

Dushyant V. Sahani, A. Gregory Sorensen, Rakesh K. Jain, 2009, Nature Reviews Clinical Oncology.

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.

Riccardo Lencioni, Andrew X. Zhu, Michel Ducreux, 2012, Journal of hepatology.